Pharmacological profile of YM358, a novel nonpeptide angiotensin AT1 receptor antagonist

By Shibasaki M.   Fujimori A.   Takanashi M.   Kusayama T.   Tokioka T.   Satoh Y.   Okazaki T.   Uchida W.   Inagaki O.   Yanagisawa I.  

European Journal of Pharmacology, Vol. 335, Iss. 2, 1997-09 ,pp. : 167-173

Elsevier

Access to resources Recommend Favorite

In vivo pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonist

By Cazes M.   Provost D.   Versigny A.   Cloarec A.  

European Journal of Pharmacology, Vol. 284, Iss. 1, 1995-09 ,pp. : 157-170

Elsevier

Access to resources Recommend Favorite

Pharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist

By Mizuno M.   Sada T.   Ikeda M.   Fukuda N.   Miyamoto M.   Yanagisawa H.   Koike H.  

European Journal of Pharmacology, Vol. 285, Iss. 2, 1995-10 ,pp. : 181-188

Elsevier

Access to resources Recommend Favorite

Pharmacological characterization of EK112, a new combined angiotensin II and thromboxane A 2 receptor antagonist

By Hwang T.-L.   Yeh Y.-A.   Chern J.-W.   Teng C.-M.  

General Pharmacology, Vol. 34, Iss. 1, 2000-01 ,pp. : 25-31

Elsevier

Access to resources Recommend Favorite

Effect of the Angiotensin II Receptor Antagonist Valsartan on Lipid Profile and Glucose Metabolism in Patients with Hypertension

By Hanefeld M   Abletshauser C  

The Journal of International Medical Research, Vol. 29, Iss. 4, 2001-07 ,pp. : 270-279

Field House Publishing

Access to resources Recommend Favorite